NYU Winthrop offers a one-year postgraduate year 2 (PGY-2) Infectious Diseases Pharmacy Residency program. You receive the training necessary to develop clinical expertise in infectious diseases pharmacotherapy and antimicrobial stewardship.
The core rotations in adult infectious diseases, antimicrobial stewardship, clinical microbiology laboratory and pediatric infectious diseases advance your knowledge of different aspects of infectious diseases and help you develop clinical skills. Additional rotations can include transplant infectious diseases, adult hematology/oncology, pediatric hematology/oncology, pediatric antimicrobial stewardship and allergy/immunology clinic.
Longitudinal involvement with the Antimicrobial Subcommittee of the Pharmacy and Therapeutics Committee and completion of a research project are required. As a resident in our program, you have a broad range of clinical and research opportunities and the flexibility to integrate your professional goals.
Number of PGY-2 Positions: One
Start Date: July 1, 2021
Application Deadline: January 5, 2021
Benefits: Comprehensive health insurance, 10 vacation days, conference days
Infectious Diseases Pharmacy Residency Eligibility Requirements
Applicants to our PGY-2 Infectious Diseases Pharmacy Residency program must possess a PharmD degree from an Accreditation Council for Pharmacy Education (ACPE)–accredited college or school of pharmacy. You must also have completed a PGY-1 Pharmacy Practice Residency and be licensed or eligible for licensure in New York state.
- All official college transcripts.
- Curriculum vitae.
- Participation in the ASHP Residency Match program and Pharmacy Online Residency Centralized Application Service (PHORCAS) is required.
- Three references submitted using the reference form in PHORCAS.
- A personal statement that describes your goals and interests, motivation for completing a PGY-2 Infectious Disease Pharmacy Residency, and why you want to be a part of NYU Langone Winthrop Hospital.
- An on-site interview, if requested, is also required and will be conducted at the applicant’s expense.
Please submit application material through PHORCAS by January 5, 2021.
Residency Program Director: Sharon Blum, PharmD, BCPS, BCIDP
ASHP: Pre-accreditation phase